Moreover, aberrant activation of NOTCH3-SLUG axis is correlated with chemo-resistance in NPC and poor prognosis of NPC patients, while targeting NOTCH3 signaling significantly resensitized NPC cells to paclitaxel. Here, NOTCH3 is linked to nasopharyngeal carcinoma.